Human Liver Models Market by Drug Discovery Platform (Non-alcoholic Fatty Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models, 3D Bioprinting), and Region (North America, Europe, Asia Pacific, Rest of the World) - Global Forecast to 2022

ヒト肝臓モデルの世界市場予測(~2022年)

◆タイトル:Human Liver Models Market by Drug Discovery Platform (Non-alcoholic Fatty Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models, 3D Bioprinting), and Region (North America, Europe, Asia Pacific, Rest of the World) - Global Forecast to 2022
◆商品コード:BT6218
◆調査・発行会社:MarketsandMarkets
◆発行日:2018年4月26日
◆ページ数:39
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥632,800見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥744,800見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥912,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、ヒト肝臓モデルの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、創薬プラットフォーム別分析、地域別分析、ヒト肝臓モデルの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The global human liver models market is projected to reach USD 2.56 Billion by 2022 from USD 1.35 Billion in 2017, at a CAGR of 13.6%. The growth of this market is primarily driven by factors such as the growing focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of liver models, growing initiatives to increase awareness about liver organoids, increasing research activities on liver organoids, increasing prevalence of non-alcoholic fatty liver disease, and growing need for the early detection of drug toxicity to minimize financial losses due to late-stage drug failure.
The human liver model market is segmented on the basis of type and region. Based on type, the market is segmented into liver organoids, liver-on-a-chip, 2D models, animal models, and 3D bioprinting.

In 2017, the animal models segment accounted for the largest share of the global market. The growth in the biosimilars market is expected to boost the preclinical market as the development of biosimilars and biopharmaceuticals requires an understanding of the mechanism of action, quantification of pharmacological effects, and interpretation of toxicological data. As animal models are indispensable for learning the disease pathogenesis and progression in humans, the rising demand for preclinical services is expected to drive the demand for animal models. However, the liver-on-a-chip segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the simplicity of this model and the ability of on-chip hepatic tissues to maintain metabolic activity and phenotype similar to that of the in vivo environment.

Geographic segments in this report include North America, Europe, Asia Pacific, and the RoW. Of these, the North American segment accounted for the largest share of the market in 2017. The human liver market for North America is driven by the presence of a well-established life sciences industry, growing awareness about the organoids technology, increasing government funding, growing incidence of NAFLD, and unavailability of livers for transplantation, increasing investments on research, rising focus on tissue culture-based clinical diagnostics, and the availability of skilled professionals.

Human Liver Models Market

Issues related to the incorporation of organoids into existing workflows are expected to restrain the growth of this market during the forecast period to a certain extent. The key players in the global human liver model market are Emulate (US), Ascendance Bio (US), HìREL (US), CN Bio (UK), Organovo (US), and Cyfuse Biomedical (Japan).

【レポートの目次】

1 Market Overview for Human Liver Models (Page No. – 8)
1.1 Introduction
1.2 Market Dynamics
1.2.1 Drivers
1.2.1.1 Growing Focus on Developing Alternatives for Animal Testing Models
1.2.1.2 Significant Increase in Research Funding and Venture Capital Investments for the Development of Liver Organoids
1.2.1.3 Growing Initiatives to Increase Awareness About Liver Organoids
1.2.1.4 Increasing Research Activities on Liver Organoids
1.2.1.5 Increasing Prevalence of Non-Alcoholic Fatty Liver Disease
1.2.1.6 Growing Need for the Early Detection of Drug Toxicity to Minimize Financial Losses Due to Late-Stage Drug Failure
1.2.2 Restraints
1.2.2.1 Issues Related to the Incorporation of Organoids Into Existing Workflows
1.2.3 Opportunities
1.2.3.1 Increasing Focus on Drug Discovery Activities
1.2.3.2 Rising Demand for Liver Transplantation
1.2.3.3 Growing Healthcare Market in the Asia Pacific and Latin America
1.2.4 Challenges
1.2.4.1 Dearth of Skilled Professionals

2 Industry Speaks – In Vitro Liver Models (Page No. – 17)

3 Human Liver Model Market, By Drug Discovery Platform (Page No. – 20)
3.1 Introduction
3.1.1 Liver Organoids
3.1.2 Liver-On-A-Chip
3.1.3 2D Models
3.1.4 Animal Models
3.1.5 3D Bioprinting

4 Geographic Assessment (Page No. – 27)
4.1 Introduction
4.2 North America
4.2.1 US
4.2.2 Canada
4.3 Europe
4.4 Asia Pacific
4.4.1 China
4.4.2 Japan
4.4.3 India
4.4.4 Rest of Asia Pacific
4.5 Rest of the World
4.6 Author Details

List of Tables (7 Tables)

Table 1 Research Projects and Activities
Table 2 Limitations of Existing Cell Model Systems
Table 3 Scientific and Ethical Comparison of Animal Models, Human Embryo Tissues, and Organoid Models
Table 4 Global Human Liver Model Market, By Type, 2015-2022 (USD Million)
Table 5 Liver-On-A-Chip Market, By Region, 2015-2022 (USD Thousand)
Table 6 Animal Models Market, By Region, 2015-2022 (USD Million)
Table 7 3D Bioprinting Market, By Region, 2015-2022 (USD Million)

List of Figures (2 Figures)

Figure 1 Human Liver Models Market: Drivers, Restraints, Opportunities, & Challenges
Figure 2 Number of Registered Clinical Trial Studies (2005–2017)



【レポートのキーワード】

ヒト肝臓モデル

★調査レポート[ヒト肝臓モデルの世界市場予測(~2022年)] ( Human Liver Models Market by Drug Discovery Platform (Non-alcoholic Fatty Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models, 3D Bioprinting), and Region (North America, Europe, Asia Pacific, Rest of the World) - Global Forecast to 2022 / BT6218) 販売に関する免責事項
[ヒト肝臓モデルの世界市場予測(~2022年)] ( Human Liver Models Market by Drug Discovery Platform (Non-alcoholic Fatty Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models, 3D Bioprinting), and Region (North America, Europe, Asia Pacific, Rest of the World) - Global Forecast to 2022 / BT6218) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆